HALO

Halozyme Therapeutics Inc (HALO)

US
$ 47.9099-4.62%

Price Chart

Key Statistics

Market Cap
$ 6.57B
P/E Ratio
14.17
Revenue (TTM)
$ 1.08B
Volume
7.26M
52W High
$ 70.51
52W Low
$ 42.01
Dividend Yield
0.00%
Beta
1.26

Technicals

50-Day MA
60.6784
200-Day MA
56.3674
52 Week High
70.51
52 Week Low
42.01

About HALO

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Employees
350
Headquarters
San Diego, CA
CEO
Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg